Annovis Bio, Inc. - COM (ANVS)

Historical Portfolio Holders from Q1 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
1.17M
Holdings value Q3 2024
$9.43M
Value change Q3 2024
+$1.85M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
34
Number of buys Q3 2024
21
Number of sells Q3 2024
-10
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.17M $9.43M +$1.85M $8.06 37
2024 Q2 984K $5.67M -$2.07M $5.76 38
2024 Q1 1.19M $14.2M -$405K $11.90 38
2023 Q4 1.2M $22.5M +$2.42M $18.70 39
2023 Q3 1.11M $10.5M -$1.63M $9.49 27
2023 Q2 1.28M $18.3M +$7.49M $14.29 26
2023 Q1 752K $11.6M +$249K $15.41 21
2022 Q4 736K $9.89M +$231K $13.43 21
2022 Q3 719K $9.85M -$399K $13.70 20
2022 Q2 770K $8.74M -$1.48M $11.33 24
2022 Q1 889K $11.9M -$3.78M $13.35 22
2021 Q4 1.12M $19.6M -$2.6M $17.58 29
2021 Q3 1.14M $36.2M -$24.7M $31.74 36
2021 Q2 1.27M $109M +$39.3M $85.59 56
2021 Q1 834K $23.1M +$2.87M $27.90 29
2020 Q4 760K $5.73M +$93.8K $7.55 12
2020 Q3 316K $1.52M +$388K $4.81 11
2020 Q2 244K $1.06M +$221K $4.35 8
2020 Q1 193K $580K +$580K $3.01 6